Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 27, 2026, IRIDEX Corporation (the “Company”) received a notification of non-compliance (the “Notice”) from Nasdaq’s Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the minimum bid price of the Company’s common stock had been below the $1.00 per share minimum requirement fo…

Results of Operations and Financial Condition. On August 18, 2026, IRIDEX Corporation issued a press release discussing its financial results for its second fiscal quarter ended July 4, 2026. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities…

Results of Operations and Financial Condition. On May 19, 2026, IRIDEX Corporation issued a press release discussing its financial results for its first fiscal quarter ended April 4, 2026. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Ac…

Results of Operations and Financial Condition. On March 26, 2026, IRIDEX Corporation (the "Company") issued a press release discussing its financial results for its fourth fiscal quarter ended January 3, 2026. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing un…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth under

Entry into a Material Definitive Agreement. On March 9, 2026, IRIDEX Corporation (the “Company”) and SFIII Hellyer, LLC and SFIII FOS Hellyer Holding, LLC (the “Landlord”) entered into a triple net lease (the “Lease”) pursuant to which the Company will lease office space located at 5215 Hellyer Avenue in San Jose, California (the “Leased Space”) as the Company’s new corporate headquarters. The Leased Space consists of approximately 30,784 square feet. The Lease term is anticipated to commence…

Results of Operations and Financial Condition. On January 12, 2026, IRIDEX Corporation (the "Company") announced its preliminary, unaudited operational and financial results for its fourth fiscal quarter and full fiscal year ended January 3, 2026. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or inco…

Results of Operations and Financial Condition. On November 11, 2025, IRIDEX Corporation issued a press release discussing its financial results for its third fiscal quarter ended September 27, 2025. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Sec…

Results of Operations and Financial Condition. On August 12, 2025, IRIDEX Corporation issued a press release discussing its financial results for its second fiscal quarter ended June 28, 2025. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securitie…

Entry Into a Material Definitive Agreement. On May 20, 2025, IRIDEX Corporation, a Delaware corporation (the “Company”) amended that certain Investor Rights Agreement, dated March 19, 2025, by and between the Company and Novel Inspiration International Co., Ltd. (the “Amendment No. 1 to Investor Rights Agreement”). Pursuant to the Amendment No.1 to the Investor Rights Agreement, the Company agreed that it shall not, without the unanimous consent of the board of directors, consummate any sale,…

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 14, 2025, IRIDEX Corporation (the “Company”) received a notification of non-compliance (the “Notice”) from Nasdaq’s Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon its Quarterly Report on Form 10-Q for the quarterly period ended March 29, 2025 that was filed with the Securities and Exchange Commission (the…

Results of Operations and Financial Condition. On May 13, 2025, IRIDEX Corporation issued a press release discussing its financial results for its first fiscal quarter ended March 29, 2025. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities A…

Results of Operations and Financial Condition. On April 14, 2025, IRIDEX Corporation (the "Company") announced its preliminary, unaudited operational and financial results for its first fiscal quarter ended March 29, 2025. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in…

Results of Operations and Financial Condition. On March 27, 2025, IRIDEX Corporation (the "Company") issued a press release discussing its financial results for its fourth fiscal quarter ended December 28, 2024. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing…

Creation of Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. The information relating to the Notes and the Note Purchase Agreement as set forth in

Director — William Moore, Nick Chen: Two new directors were appointed to the Board of Directors as part of a Rights Agreement.

Entry Into a Material Definitive Agreement. On March 19, 2025, IRIDEX Corporation, a Delaware corporation (the “Company”) entered into the Securities Purchase Agreement (the “Securities Agreement”) and the Note Purchase Agreement (the “Note Purchase Agreement”, and together with the Securities Agreement, the Notes (as defined below) and the Rights Agreement (as defined below, the “Transaction Documents”) with Novel Inspiration International Co., Ltd. (the “Investor” or “Novel”). Pursuant to t…

Termination of a Material Definitive Agreement. The information relating to the Repayment Notice, the Lind Purchase Agreement and the Lind Note set forth in

Unregistered Sales of Equity Securities The information contained above under

Results of Operations and Financial Condition. On January 14, 2025, IRIDEX Corporation (the "Company") announced its preliminary, unaudited operational and financial results for its fourth fiscal quarter and full fiscal year ended December 28, 2024. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or in…

Chief Executive Officer — Dave Bruce: Mr. Bruce was terminated as CEO and later resigned from the Board with severance benefits.

Director — Patrick Mercer: Patrick Mercer, the current President, CEO, and COO of IRIDEX Corporation, was appointed to serve as a member of the Board.

CEO — Dave Bruce: David Bruce was terminated as CEO and resigned from the Board.

Results of Operations and Financial Condition. On November 12, 2024, IRIDEX Corporation (the "Company") issued a press release discussing its financial results for its third fiscal quarter ended September 28, 2024. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any fili…

Chief Executive Officer — Patrick Mercer: Patrick Mercer was promoted to Chief Executive Officer and will continue as President and COO.